93 related articles for article (PubMed ID: 2173804)
1. The location of the Philadelphia chromosomal breakpoint site and prognosis in chronic granulocytic leukemia.
Tefferi A; Bren GD; Wagner KV; Schaid DJ; Ash RC; Thibodeau SN
Leukemia; 1990 Dec; 4(12):839-42. PubMed ID: 2173804
[TBL] [Abstract][Full Text] [Related]
2. The location of breakpoints within the breakpoint cluster region (bcr) of chromosome 22 in chronic myeloid leukemia.
Eisenberg A; Silver R; Soper L; Arlin Z; Coleman M; Bernhardt B; Benn P
Leukemia; 1988 Oct; 2(10):642-7. PubMed ID: 3172841
[TBL] [Abstract][Full Text] [Related]
3. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.
Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S
Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454
[TBL] [Abstract][Full Text] [Related]
4. Mapping of breakpoints, and relationship to BCR-ABL RNA expression, in Philadelphia-chromosome-positive chronic myeloid leukaemia patients with a breakpoint around exon 14 (b3) of the BCR gene.
Mills KI; Sproul AM; Leibowitz D; Burnett AK
Leukemia; 1991 Nov; 5(11):937-41. PubMed ID: 1961034
[TBL] [Abstract][Full Text] [Related]
5. [BCR rearrangement and cytogenetic findings in Philadelphia-positive chronic myelocytic leukemia in children].
Shikano T; Kikuta H; Ishikawa Y; Naito H; Ohkawa M; Nakadate N; Hatae Y; Takeda T
Rinsho Ketsueki; 1989 Jan; 30(1):29-35. PubMed ID: 2716196
[TBL] [Abstract][Full Text] [Related]
6. The first BCR gene intron contains breakpoints in Philadelphia chromosome positive leukemia.
Heisterkamp N; Knoppel E; Groffen J
Nucleic Acids Res; 1988 Nov; 16(21):10069-81. PubMed ID: 3194194
[TBL] [Abstract][Full Text] [Related]
7. Consistent involvement of the bcr gene by 9;22 breakpoints in pediatric acute leukemias.
Suryanarayan K; Hunger SP; Kohler S; Carroll AJ; Crist W; Link MP; Cleary ML
Blood; 1991 Jan; 77(2):324-30. PubMed ID: 1985699
[TBL] [Abstract][Full Text] [Related]
8. [Chronic myeloid leukemia: cytogenetic and molecular study and its relationship with the disease course].
Lira P; Barriga F; Risueño C; Alfaro J; Legues ME; Grebe G
Rev Med Chil; 1993 Aug; 121(8):864-72. PubMed ID: 8296093
[TBL] [Abstract][Full Text] [Related]
9. M-BCR breakpoint location does not predict survival in Philadelphia chromosome-positive chronic myeloid leukemia.
Zaccaria A; Martinelli G; Buzzi M; Zuffa E; Zamagni MD; Testoni N; Russo D; Guerrasio A; Saglio G; Tura S
Haematologica; 1992; 77(1):16-20. PubMed ID: 1398276
[TBL] [Abstract][Full Text] [Related]
10. Breakpoint localization within the M-bcr and clinical course do not correlate in patients with chronic myelogenous leukemia undergoing alfa interferon therapy.
Opalka B; Wandl U; Beer U; Roggenbuck U; Kloke O; Niederle N
Leukemia; 1991 Jun; 5(6):452-6. PubMed ID: 2056769
[TBL] [Abstract][Full Text] [Related]
11. Clinical stage of chronic granulocytic leukaemia and BCR breakpoint location in South-East Asian patients.
Dyck JA; Bosco JJ
Br J Haematol; 1989 May; 72(1):64-7. PubMed ID: 2736243
[TBL] [Abstract][Full Text] [Related]
12. Analysis of breakpoints within the bcr gene and their correlation with the clinical course of Philadelphia-positive chronic myelogenous leukemia.
Shtalrid M; Talpaz M; Kurzrock R; Kantarjian H; Trujillo J; Gutterman J; Yoffe G; Blick M
Blood; 1988 Aug; 72(2):485-90. PubMed ID: 3165294
[TBL] [Abstract][Full Text] [Related]
13. Philadelphia-chromosome-positive T-lymphoblastic leukemia: acute leukemia or chronic myelogenous leukemia blastic crisis.
Raanani P; Trakhtenbrot L; Rechavi G; Rosenthal E; Avigdor A; Brok-Simoni F; Leiba M; Amariglio N; Nagler A; Ben-Bassat I
Acta Haematol; 2005; 113(3):181-9. PubMed ID: 15870488
[TBL] [Abstract][Full Text] [Related]
14. Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia.
Anastasi J; Feng J; Dickstein JI; Le Beau MM; Rubin CM; Larson RA; Rowley JD; Vardiman JW
Leukemia; 1996 May; 10(5):795-802. PubMed ID: 8656674
[TBL] [Abstract][Full Text] [Related]
15. Megakaryocytic blast crisis in a chronic myeloid leukemia patient with a rare variant of Philadelphia rearrangement t(9;22;22) and a constitutional translocation t(3;7).
Jarmuz M; Kroll R; Przybyłowicz-Chalecka A; Ratajczak B; Gniot M; Szyfter K; Komarnicki M
Cancer Genet Cytogenet; 2010 May; 199(1):45-7. PubMed ID: 20417868
[TBL] [Abstract][Full Text] [Related]
16. Correlation of the site of M-bcr breakpoint with chronic phase duration, blastic crisis lineage and thrombocytosis in Ph1-positive chronic myelogenous leukemia.
Viniou NA; Matzourani M; Yataganas X; Meletis J; Pangalis G; Loukopoulos D
Leuk Lymphoma; 1995 Jul; 18(3-4):335-9. PubMed ID: 8535202
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of the blast phase of chronic granulocytic leukemia.
Canellos GP
Hematol Oncol Clin North Am; 1990 Apr; 4(2):359-67. PubMed ID: 2182596
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of a DNA probe assay for the Philadelphia (Ph1) translocation in chronic myelogenous leukemia.
Blennerhassett GT; Furth ME; Anderson A; Burns JP; Chaganti RS; Blick M; Talpaz M; Dev VG; Chan LC; Wiedemann LM
Leukemia; 1988 Oct; 2(10):648-57. PubMed ID: 3050293
[TBL] [Abstract][Full Text] [Related]
19. [Cytogenetic and clinical features of Philadelphia chromosome positive leukemias].
Becher R; Kloke O
Verh Dtsch Ges Pathol; 1990; 74():36-42. PubMed ID: 1708614
[TBL] [Abstract][Full Text] [Related]
20. Relationship of the BCR gene breakpoint and the type of BCR/ABL transcript to clinical course, prognostic indexes and survival in patients with chronic myeloid leukemia.
Prejzner W
Med Sci Monit; 2002 May; 8(5):BR193-7. PubMed ID: 12011769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
